TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ACTU

Actuate Therapeutics, Inc.

Healthcare · Biotechnology

0.9812$ -1.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Actuate Therapeutics, Inc. (ACTU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 14 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACTU
Line item 2022 2023 2024 2025
20 3.0 9.3 14
20 3.0 9.2 14
20 3.0 8.6 13
20 3.0 8.6 13
5.7 103 9.2 6.1
4.3 6.9 8.8 5.7
2.1 3.4 1.9 1.5
15 -100 0.1 7.9
-80 -105 -132 -155
15 15 20 21

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?